Literature DB >> 2332269

Serous psammocarcinoma of the ovary and peritoneum.

C B Gilks1, D A Bell, R E Scully.   

Abstract

We report 11 cases of serous psammocarcinoma, a rare variant of serous carcinoma characterized by massive psammoma body formation and low-grade cytological features. The patients ranged in age from 36 to 76 (mean of 57) years. The tumors were stage three in every case (three stage IIIA, seven stage IIIB, and one stage IIIC). Eight of the patients had ovarian psammocarcinomas with ovarian tumors measuring 5-22 (mean of 11) cm in diameter; the other three patients had primary peritoneal psammocarcinomas. The surfaces of the ovarian tumors were smooth and intact in seven of eight ovarian psammocarcinomas. Cysts were present in six of eight ovarian tumors, and the solid portions were typically gritty or granular. Necrosis was not seen. Microscopically there was destructive invasion of ovarian stroma or vascular invasion in the ovarian tumors; the extraovarian tumor implants were invasive of intraperitoneal viscera in five cases. The epithelium was arranged in small nests with no areas of solid epithelial proliferation, and at least 75% of the epithelial nests were associated with psammoma body formation. No more than moderate nuclear atypicality was identified in any case. No mitotic figures were found in 10 of the tumors, with a single mitotic figure identified in the other tumor. Follow-up data for more than 1 year was available for six patients, with two patients lost to follow-up and three patients followed without evidence of recurrence for less than 1 year. One patient died of tumor 6 1/2 years after presentation, and five patients were alive without evidence of recurrent tumor 3-10 (mean of 8.3) years after presentation. Although based on a small number of cases, these data suggest that the clinical behavior of psammocarcinoma more closely resembles that of borderline serous tumors than of serous carcinomas of the usual type, following a protracted course and being associated with a relatively favorable prognosis.

Entities:  

Mesh:

Year:  1990        PMID: 2332269     DOI: 10.1097/00004347-199004000-00002

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  11 in total

1.  Elevated CA125 in primary peritoneal serous psammocarcinoma: a case report and review of the literature.

Authors:  Deng Zhen-Zhong; Ning Zheng; Heng Liu; Dong-Ying Liao; Xiao-Qin Ye; Qiu-Ming Zhou; Huai-Hui Li; Qi Liu; Kang-Min Lu
Journal:  BMJ Case Rep       Date:  2009-05-26

Review 2.  Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.

Authors:  Murray Joseph Casey; Chhanda Bewtra
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

3.  Extensive psammomatous calcification of the uterus and cervix associated with a uterine serous carcinoma.

Authors:  R I Cameron; W G McCluggage
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

4.  Acute gastric outlet obstruction secondary to papillary serous adenocarcinoma of the endometrium with peritoneal psammomatous implants: a case report.

Authors:  John Morgan; Michael A Sadler
Journal:  Emerg Radiol       Date:  2009-01-09

Review 5.  Low-grade serous ovarian cancer: a unique disease.

Authors:  Kathleen M Schmeler; David M Gershenson
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

6.  Imaging of serous psammomacarcinoma of ovary with subcutaneous deposits: A case report.

Authors:  Nagaraj Diwakar; Ravindra B Kamble; Jagannath Dixit; Dashavara Sreekantaiah Gangadhara; Roshan V Shetty
Journal:  Indian J Radiol Imaging       Date:  2011-04

7.  Abdominopelvic washings: A comprehensive review.

Authors:  Erika F Rodriguez; Sara E Monaco; Walid Khalbuss; R Marshall Austin; Liron Pantanowitz
Journal:  Cytojournal       Date:  2013-04-24       Impact factor: 2.091

8.  Psammocarcinoma of ovary with serous cystadenofibroma of contralateral ovary: a case report.

Authors:  Deepali Jain; L Akhila; Vibha Kawatra; Pallavi Aggarwal; Nita Khurana
Journal:  J Med Case Rep       Date:  2009-12-15

9.  Prevalence and significance of psammoma bodies in cervicovaginal smears in a cervical cancer screening program with emphasis on a case of primary bilateral ovarian psammocarcinoma.

Authors:  Teresa Pusiol; Anna M Parolari; Irene Piscioli; Luca Morelli; Franca Del Nonno; Stefano Licci
Journal:  Cytojournal       Date:  2008-04-16       Impact factor: 2.091

10.  Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma.

Authors:  Saubhagya Kumar Jena; Pritinanda Mishra; Vandana Mohapatra; Sweta Singh
Journal:  Case Rep Obstet Gynecol       Date:  2015-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.